The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2016 | Selecting and managing patients for targeted therapies and immunotherapies for lung cancer
Rachel Thomas, lung cancer clinical nurse specialist at Guy’s and St Thomas’ NHS Foundation Trust, London, UK talks about the selecting eligible patients for targeted therapies based on their mutational status. She also describes the role of nurses in preparing patients for treatment, providing them with information on the treatment type and what to expect, and helping them manage side effects.
Recorded at the 2016 World Congress of Lung Cancer (WCLC) of the International Association for the Study of Lung Cancer (IASLC) in Vienna, Austria.
